Literature DB >> 23182394

Small bowel dose parameters predicting grade ≥ 3 acute toxicity in rectal cancer patients treated with neoadjuvant chemoradiation: an independent validation study comparing peritoneal space versus small bowel loop contouring techniques.

Robyn Banerjee1, Santam Chakraborty, Ian Nygren, Richie Sinha.   

Abstract

PURPOSE: To determine whether volumes based on contours of the peritoneal space can be used instead of individual small bowel loops to predict for grade ≥3 acute small bowel toxicity in patients with rectal cancer treated with neoadjuvant chemoradiation therapy. METHODS AND MATERIALS: A standardized contouring method was developed for the peritoneal space and retrospectively applied to the radiation treatment plans of 67 patients treated with neoadjuvant chemoradiation therapy for rectal cancer. Dose-volume histogram (DVH) data were extracted and analyzed against patient toxicity. Receiver operating characteristic analysis and logistic regression were carried out for both contouring methods.
RESULTS: Grade ≥3 small bowel toxicity occurred in 16% (11/67) of patients in the study. A highly significant dose-volume relationship between small bowel irradiation and acute small bowel toxicity was supported by the use of both small bowel loop and peritoneal space contouring techniques. Receiver operating characteristic analysis demonstrated that, for both contouring methods, the greatest sensitivity for predicting toxicity was associated with the volume receiving between 15 and 25 Gy.
CONCLUSION: DVH analysis of peritoneal space volumes accurately predicts grade ≥3 small bowel toxicity in patients with rectal cancer receiving neoadjuvant chemoradiation therapy, suggesting that the contours of the peritoneal space provide a reasonable surrogate for the contours of individual small bowel loops. The study finds that a small bowel V15 less than 275 cc and a peritoneal space V15 less than 830 cc are associated with a less than 10% risk of grade ≥3 acute toxicity.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23182394     DOI: 10.1016/j.ijrobp.2012.09.036

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

1.  Influence of position and radiation technique on organs at risk in radiotherapy of rectal cancer.

Authors:  Jun-Feng Wang; Hui Li; Hua Xiong; He Huang; Yan-Mei Zou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

2.  An autoimmune-based, paraneoplastic neurologic syndrome following checkpoint inhibition and concurrent radiotherapy for merkel cell carcinoma: case report.

Authors:  Alexander D Sherry; Michael Bezzerides; Mohamed H Khattab; Guozhen Luo; Kristin K Ancell; Austin N Kirschner
Journal:  Strahlenther Onkol       Date:  2020-01-31       Impact factor: 3.621

3.  Predictors of late bowel toxicity using three different methods of contouring in patients undergoing post-operative radiation for cervical cancer.

Authors:  Supriya Chopra; Rahul Krishnatry; Tapas Dora; Sadhna Kannan; Biji Thomas; Supriya Sonawone; Reena Engineer; Siji Paul; Reena Phurailatpam; Umesh Mahantshetty; Shyam Shrivastava
Journal:  Br J Radiol       Date:  2015-09-22       Impact factor: 3.039

4.  NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer.

Authors:  Theodore S Hong; Jennifer Moughan; Michael C Garofalo; Johanna Bendell; Adam C Berger; Nicklas B E Oldenburg; Pramila Rani Anne; Francisco Perera; R Jeffrey Lee; Salma K Jabbour; Adam Nowlan; Albert DeNittis; Christopher Crane
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-05-14       Impact factor: 7.038

5.  Is the irradiated small bowel volume still a predictor for acute lower gastrointestinal toxicity during preoperative concurrent chemo-radiotherapy for rectal cancer when using intensity-modulated radiation therapy?

Authors:  Benhua Xu; Yuyan Guo; Yuangui Chen; Haijie Lu; Tianlan Tang; Zhicao Yue; Guoxian Guan; Pan Chi; Chi Lin
Journal:  Radiat Oncol       Date:  2015-12-18       Impact factor: 3.481

6.  In vivo Portal Imaging Dosimetry Identifies Delivery Errors in Rectal Cancer Radiotherapy on the Belly Board Device.

Authors:  Stefano Peca; Richie Siddhartha Sinha; Derek Wilson Brown; Wendy Lani Smith
Journal:  Technol Cancer Res Treat       Date:  2017-06-06

7.  Reduced dose to small bowel with the prone position and a belly board versus the supine position in neoadjuvant 3D conformal radiotherapy for rectal adenocarcinoma.

Authors:  Rohen White; Farshad Foroudi; Joseph Sia; Mary Ann Marr; Daryl Lim Joon
Journal:  J Med Radiat Sci       Date:  2016-07-28

8.  A randomized study of the effect of patient positioning on setup reproducibility and dose distribution to organs at risk in radiotherapy of rectal cancer patients.

Authors:  Trude C Frøseth; Trond Strickert; Kjersti S Solli; Øyvind Salvesen; Gunilla Frykholm; Randi J Reidunsdatter
Journal:  Radiat Oncol       Date:  2015-10-27       Impact factor: 3.481

9.  Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer.

Authors:  Hendrik Dapper; Markus Oechsner; Stefan Münch; Kai Borm; Jan Peeken; Michael Mayinger; Stephanie E Combs; Daniel Habermehl
Journal:  Radiat Oncol       Date:  2018-09-06       Impact factor: 3.481

10.  Evaluation of small bowel motion and feasibility of using the peritoneal space to replace bowel loops for dose constraints during intensity-modulated radiotherapy for rectal cancer.

Authors:  Siyuan Li; Yanping Gong; Yongqiang Yang; Qi Guo; Jianjun Qian; Ye Tian
Journal:  Radiat Oncol       Date:  2020-09-01       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.